Mangone, Lucia
Pinto, Carmine
Mancuso, Pamela
Ottone, Marta
Bisceglia, Isabella
Chiaranda, Giorgio
Michiara, Maria
Vicentini, Massimo
Carrozzi, Giuliano
Ferretti, Stefano
Falcini, Fabio
Hassan, Cesare
Rossi, Paolo Giorgi
Article History
Received: 11 November 2020
Accepted: 19 February 2021
First Online: 12 May 2021
Declarations
:
: We declare that all methods used were conducted in accordance with the guidelines on the use of data collected in humans; all data are anonymised and treated following the GDPR and Italian regulations. The presented analyses have been conducted under the authorization given by the Regional bill DGR number 582 date 2013 that instituted the regional pathology registries for screening targeted cancers. The registry is aimed at studying the epidemiology of breast, colorectal and cervical cancer epidemiology, particularly aiming at monitoring screening and care effectiveness. The DGR 582/2013 is available at ExternalRef removedThis study protocol received Institutional Review Board approval from the Romagna Cancer Institute (protocol ID: IRST100.37). In Italy, the documentation and monitoring of screening and surveillance outcomes (including monitoring and reporting screening activity at the centre and operator level) is part of a planned evaluation activity.
: The Institutional Review Board approval from the Romagna Cancer Institute (protocol ID: IRST100.37) authorised to use patients’ data even in the absence of consent if it would not be possible to contact them, given that all the reasonable efforts to contact them have done.
: The Authors declare that they have no competing interest.